Notes from Dr. Terry
A 2016 randomized clinical trial [http://hepatmon.com/?page=article&article_id=34897 ] examined the effectiveness of ginger as a treatment for nonalcoholic fatty liver disease. This condition is increasing in prevalence as the incidence of metabolic syndrome and obesity increases.
Several markers of liver inflammation were measured in 44 patients randomized to either a placebo or active treatment group. The authors found that ginger improved insulin resistance and fasting glucose levels; significantly lowered the severity of steatosis (the fatty infiltration of the liver) in fatty livers as examined by ultrasound; and significantly reduced several markers of liver inflammation including ALT, hsCRP, TNF-𝛂, and GGT. The most significant reduction was seen in steatosis as visualized on ultrasound (p<0.001). There was no change meanwhile in AST or level of fibrosis (also visualized on ultrasound).
The active treatment group (N=23) was administered ginger powder at a rate of 1,000 mg twice per day. St. Francis Herb Farm’s ginger capsules contain 200mg of 5:1 extract, equivalent to 1,000 mg of crude powdered ginger. So, one capsule of our product twice per day is equivalent to the dose used in this clinical trial. Meanwhile, St. Francis Herb Farm’s fluidextract of ginger has the equivalent of 1,000 mg of crude powdered ginger per ml, thus 1 ml twice per day would be equivalent to the dose studied.
Read the research summary: Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study http://hepatmon.com/?page=article&article_id=34897
Dr. Terry Vandeheyden is a naturopathic doctor, registered herbalist and St. Francis Herb Farm medical advisor.